Viewing Study NCT06075667


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-03-15 @ 4:39 AM
Study NCT ID: NCT06075667
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-25
First Post: 2023-10-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module